Vise Technologies’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.26M Buy
9,520
+738
+8% +$153K 0.03% 498
2026
Q1
$1.8M Hold
8,782
– – 0.04% 402
2025
Q4
$1.8M Buy
8,782
+4,193
+91% +$789K 0.04% 403
2025
Q3
$720K Sell
4,589
-1,428
-24% -$221K 0.03% 523
2025
Q2
$1.01M Buy
+6,017
New +$893K 0.04% 426
2024
Q4
$255K Buy
+2,153
New +$251K 0.02% 666
2022
Q3
– Sell
-4,153
Closed -$217K – 305
2022
Q2
$217K Sell
4,153
-8,764
-68% -$498K 0.08% 264
2022
Q1
$732K Sell
12,917
-15,080
-54% -$808K 0.28% 89
2021
Q4
$1.44M Buy
+27,997
New +$1.37M 0.39% 58

Other funds holding CAH

Vise Technologies's CAH Position: Q2 2026 in Review

Vise Technologies increased its Cardinal Health (CAH) stake by 8.4% in Q2 2026, buying an estimated $153K and bringing the position to 9,520 shares worth $2.26M. The position accounts for 0.03% of the portfolio, ranked #498.

Vise Technologies first reported a position in CAH in Q4 2021 and has held it in 9 quarters since. 1,500 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Vise Technologies held 9,520 shares of Cardinal Health worth $2.26M as of Q2 2026.
  • Vise Technologies bought 738 Cardinal Health shares in Q2 2026, an estimated $153K.
  • Cardinal Health made up 0.03% of Vise Technologies's portfolio in Q2 2026, its #498 holding.
  • Vise Technologies first reported a position in Cardinal Health in Q4 2021 and has held it in 9 quarters since.
  • 1,500 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Vise Technologies's 13F filing for Q2 2026, filed 11 Aug 2026.